Erick DeVinney
Corporate Officer/Principal chez AXOGEN, INC.
Fortune : 1 M $ au 30/04/2024
Postes actifs de Erick DeVinney
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AXOGEN, INC. | Corporate Officer/Principal | 04/01/2024 | - |
| Directeur Technique/Scientifique/R&D | 01/04/2007 | 04/01/2024 |
Historique de carrière de Erick DeVinney
Anciens postes connus de Erick DeVinney
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
AxoGen Corp.
 AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | Directeur Technique/Scientifique/R&D | 01/04/2007 | 01/01/2014 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 01/01/2005 | 01/01/2007 |
National Clinical Research Centers, Inc.
 National Clinical Research Centers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., National Clinical Research Centers, Inc. is a company that specializes in clinical trials management and pharmaceuticals. The company is based in Bethesda, MD. The company was founded by Stephen J. Trevisan. National Clinical Research Centers was acquired by Roberts Pharmaceutical Corp., part of Takeda Pharmaceutical Co., Ltd. from December 23, 1999 on April 07, 1992 for $6.25 million. | Corporate Officer/Principal | - | - |
| Medical College of Virginia | Corporate Officer/Principal | - | - |
Formation de Erick DeVinney
| Virginia Commonwealth University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Canada | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AXOGEN, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
AxoGen Corp.
AxoGen Corp. BiotechnologyHealth Technology Part of Axogen, Inc., AxoGen Corp. develops peripheral nerve grafting and regeneration technologies. The company is based in Alachua, FL. The company was founded in 2002 by John P. Engels, Jamie M. Grooms. AxoGen was acquired by LecTec Corp. on September 30, 2011 for $19.98 million. | Health Technology |
National Clinical Research Centers, Inc.
National Clinical Research Centers, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., National Clinical Research Centers, Inc. is a company that specializes in clinical trials management and pharmaceuticals. The company is based in Bethesda, MD. The company was founded by Stephen J. Trevisan. National Clinical Research Centers was acquired by Roberts Pharmaceutical Corp., part of Takeda Pharmaceutical Co., Ltd. from December 23, 1999 on April 07, 1992 for $6.25 million. | Commercial Services |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
- Bourse
- Insiders
- Erick DeVinney
- Expérience
